Toby Christie is the Editor-in-Chief of Racing America. He has 15 years of experience as a motorsports journalist and has been with Racing America since 2023.

Rich Rodriguez is desperately searching for answers at the quarterback position, and while redshirt freshman Khalil Wilkins provided a spark and flashed some promise in the loss to Utah, it doesn't ...

Max Verstappen kept his cool to take pole position for the Azerbaijan Grand Prix in Formula 1 for Red Bull, with Williams driver Carlos Sainz on the front row. The reigning world champion’s 1:41.117 ...

Questions arise over whether starting an old vehicle was the right decision. Musician Tebogo G Mashego's alleged arrest turns out to be a misunderstanding Notable People Who Died in 2025 Severe ...

The Detroit Lions lost both of their starting cornerbacks to injury in their Week 4 game against the Cleveland Browns. First, second-year corner Terrion Arnold suffered a shoulder injury while ...

The biggest stories of the day delivered to your inbox.

The NASCAR Cup Series continues in the 2025 playoffs with the opening race in the Round of 12, the Mobil 1 301 on Sept. 21 at New Hampshire. Joey Logano is on the pole, with teammate Ryan Blaney on ...

As the Dallas Cowboys get All-Pro cornerback DaRon Bland back from injury against the Green Bay Packers on Sunday night, they will put him into the starting lineup in place of another All-Pro.

Building wealth is one of the most important steps toward financial freedom, and one of the best ways to do that is through investing. However, investing often comes with a lot of jargon and complex ...

Unless Russell Wilson regains the starting quarterback role for the New York Giants following Brian Daboll's decision to replace him with Jaxson Dart's, the veteran must brace for substantial ...

Chase Briscoe is on the pole for the Hollywood Casino 400 NASCAR Cup Series race on Sept. 28 at Kansas Speedway. Briscoe's time of 29.987 seconds was 0.101 seconds faster than teammate Denny Hamlin ...

Eli Lilly has pulled the plug on a phase 2b obesity trial before enrolling a single patient, citing “strategic business reasons.” The study was designed to test bimagrumab, an asset Lilly acquired in ...